Cork cloud-based quality management software firm Qumas has been acquired by life sciences software player Accelrys Inc in a deal understood to be valued at around US$50m.
The acquisition of Qumas will enable Accelrys to help its customers manage the scientific innovation lifecycle by reducing regulatory risks and improving compliance effectiveness.
“As Accelrys continues to extend its research, laboratory and manufacturing informatics capabilities to deliver first-in-class scientific innovation lifecycle management (SILM) solutions, we’re delighted to welcome the QUMAS team and the extensive compliance, quality and regulatory expertise they bring to our company,” said Accelrys president and CEO Max Carnecchia.
“Integrating Qumas solutions into the Accelrys product portfolio will provide a single-vendor SILM solution that is already in high demand for product lifecycle management into the critical compliance and quality management arena for science-based process industries.”
Regulatory track record
Qumas has been refining the documentation of compliance with global mandates (including FDA and GxP standards) in regulated industries for 20 years.
As a result, the company has achieved an excellent track record of successfully integrating content, processes, people and systems into enterprise compliance programmes that eliminate the cost and complexity of managing paper-based as well as disparate or legacy document management applications.
“In connecting science to business and in bridging the scientific and business communities through our compliance and quality solutions, Qumas is delighted to join forces with Accelrys to help deliver this comprehensive, single-source compliance solution for the lab-to-plant continuum,” said Qumas CEO Kevin O’Leary.
“Joining the market leader in scientific innovation lifecycle management enables Qumas to extend its strong customer momentum into other business areas currently served by Accelrys.”